Managing Director, CR & CNIC INVESTMENT LIMITED
Mr. Choi was the Deputy General Manager of International Business Department of CR Capital Management, Real Estate Specialist at PAG, and Senior Manager at CBRE.
Mr. Choi received an MBA from the University of Chicago, and a bachelor’s degree from the University of Hong Kong. He is professional member of Chartered Financial Analyst Institute (CFA), the Royal Institute of Chartered Surveyors (RICS) and the Hong Kong Institute of Surveyors (HKIS).
Managing Director, CR Everbright Health Industry FOF
Mr. Ni used to be the Head of the Investment Banking Department at Ping An Bank Co., Ltd. (head office) and the General Manager of the Investment Banking Department at China Resources Bank of Zhuhai Co., Ltd. (head office). With rich experience in investment banking, he has led the institutions he has served to make numerous innovations in and important contributions to asset management, debt financing instruments, structured financing, private equity, asset securitization, and mergers and reorganization.
Mr. Ni has a PhD in Industrial Economics, an MBA, and the title of Senior Economist from Xi’an Jiaotong University.
Managing Director, Asia Food Fund
Mr. Li used to be the Director of Hony Investment and the Managing Director of AIF Capital. Involved in private equity investment for many years, he has a rich experience in state-owned enterprise restructuring, industrial integration, mergers and reorganization, and overseas M&A.
Mr. Li holds a master's degree in Business Management from Beijing Jiaotong University.
Fund Director, CR-BECE New Energy Fund and Big Data Fund
Mr. Qiu used to be the Vice President of the Investment Department at CR Capital Management, the Senior Manager of CR Financial Holding, and the Senior Manager of CR Asset Management.
Mr. Qiu holds a bachelor's degree from Boston University.
CEO, CR Pharmaceutical Fund
Mr. Tang used to be the General Manager of Yunnan Yingmao Honghe Pharmaceutical Co., Ltd., the Investment Director of the Investment Headquarters of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., the Investment Director of the Investment and Legal Affairs Department of China Resources Pharmaceutical Group Co., Ltd., the Vice Director of the Investment Management Department at Sinopharm Group Co., Ltd., and the Vice President of investment at Jumpcan Pharmaceutical Group Co., Ltd.
Mr. Tang has a vast knowledge of and research experience in biomedicine and pharmacology. He is also experienced in business operation and management and pharmaceutical investment projects. In addition, he has a great deal of experience in investment scheme design, industrial integration, value judgment, and risk control.
Mr. Tang holds a bachelor's degree in Pharmaceutical Chemistry, a master’s degree in Fine Chemistry and a PhD in Biochemistry from East China University of Science and Technology, and has qualified as a licensed pharmacist in China.
